In this NBC News Boston feature, Dotmatics executives, Kalim Saliba and Steve Tharp, discuss how artificial intelligence is transforming drug discovery and the broader healthcare industry. Bringing a new drug to market can take more than a decade and cost billions, but AI is helping researchers cut through data complexity, accelerate timelines, and improve outcomes.
Dotmatics is leading this race to AI—empowering scientists with tools that act like “a thousand lab researchers at their side.” The result: faster, more cost-effective development of life-saving therapeutics, and a future where patients gain access to safer, more personalized medicines in years instead of decades.
Watch the full interview to hear Dotmatics leaders share their perspective on how AI is reshaping the future of medicine.
Learn More About Dotmatics
Schedule a meeting with our team to learn more about Luma's AI capabilities.